Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population

Table 3

Thrombophilic genetic factors (THRGFs), PAI-1 4G-4G, MTHFR677TT, V Leiden 506Q, and Prothrombin 20210A, in patients with abdominal thrombosis with myeloproliferative neoplasm (MPN), recent abdominal surgery (RAS), oral contraception or pregnancy (OCP), chronic disease (CD), abdominal acute disease (AAD), and it a single disease or clinical status associated (NODCSA).

	MPN (%)	RAS (%)	OCP (%)	AAD (%)	CD (%)	NODCSA (%)	Total
Number of patients	37 (100)	12 (100)	10 (100)	7 (100)	9 (100)	10 (100)	85 (100)
PAI-1 4G-4G	18 (48.6)	7 (58.3)	6 (60)	4 (57.1)	6 (66.6)	6 (60.0)	47 (55.3)
MTHFR677TT	8 (21.6)	2 (16.6)	3 (30)	2 (28.5)	3 (33.3)	6 (60.0)	24 (28.2)
V Leiden 506Q	6 (16.2)	1 (8.3)	3 (30)	0 (0)	0 (0)	3 (30.0)	13 (15.3)
Prothrombin 20210A	2 (5.4)	0 (0)	0 (0)	1 (14.3)	0 (0)	2 (20.0)	5 (5.8)
>1 THRGF	5 (13.5)	1 (8.3)	2 (20.0)	0 (0)	1 (11.1)	6 (60.0)	15 (17.6)
At least 1 THRGF	28 (75.7)	10 (83.3)	10 (100)	7 (100)	9 (100)	10 (100)	73 (87.1)